Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first ...
The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...
Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...
Medical Device Network on MSN
Edwards receives FDA approval for mitral valve replacement system
The TMVR procedure with SAPIEN M3 involves dock and valve delivery via a percutaneous femoral vein guide sheath.
LONDON — Opinions about the relative value of interventions to control mitral regurgitation secondary to heart failure might be altered by two large randomized trials. The RESHAPE-HF2 trial showed ...
Edwards Lifesciences (EW) announced on Tuesday that the U.S. Food and Drug Administration approved its SAPIEN M3 ...
London, United Kingdom – 31 August 2024: There was no difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery in patients with secondary mitral regurgitation (MR), ...
A new eight-item score may predict mortality after transcatheter edge-to-edge (TEER) repair of the mitral valve, new research shows. The investigators found the "MitraScore" was also predictive for ...
TCT 635: In-Hospital Mortality and Complications After Transcatheter Edge-to-Edge Repair vs. Surgical Mitral Valve Repair in Chronic Obstructive Pulmonary Disease: A Nationwide Study Receive the the ...
NEW YORK CITY -- Newer technology strengthened the case for single-shot transcatheter edge-to-edge repair (TEER) for concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR), according ...
Please provide your email address to receive an email when new articles are posted on . Patients with severe degenerative mitral regurgitation saw sustained benefits with a novel transcatheter edge-to ...
A UK heart charity is urging the NHS to update the "small print" in its commissioning guidelines that excludes thousands of patients affected by a form of mitral regurgitation (MR) from potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results